Abstract
D-Amino acid oxidase (DAAO) catalyzes the oxidation of D-amino acids including D-serine, a full agonist at the glycine site of the NMDA receptor. A series of benzo[d]isoxazol-3-ol derivatives were synthesized and evaluated as DAAO inhibitors. Among them, 5-chlorobenzo[d]isoxazol-3-ol (CBIO) potently inhibited DAAO with an IC50 in the submicromolar range. Oral administration of CBIO in conjunction with D-serine enhanced the plasma and brain levels of D-serine in rats compared to the oral administration of D-serine alone.
Original language | English (US) |
---|---|
Pages (from-to) | 3357-3359 |
Number of pages | 3 |
Journal | Journal of medicinal chemistry |
Volume | 51 |
Issue number | 12 |
DOIs | |
State | Published - Jun 26 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery